长期的老化治疗可以预防动脉衰老中的内皮功能障碍
Jie Lin1, Shilin Chen2,3, Dong Tan3
1Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China.
Aging and disease
|November 26, 2025
概括
用达沙替尼加奎尔 (D+Q) 进行的老化治疗可以清除老化的内皮细胞,减轻动脉衰老. 这种疗法恢复了线粒体功能和氧化的产生,改善了老年小鼠的血管健康.
科学领域:
- 心血管生物学 心血管生物学
- 老年学是一门学科.
- 细胞衰老 细胞衰老
背景情况:
- 内皮衰老是动脉功能障碍和与年龄有关的心血管疾病的关键因素.
- 衰老细胞随着年龄的增长而积累,导致组织功能障碍和慢性疾病.
研究的目的:
- 研究老化疗法 (达沙替尼加奎尔塞丁,D+Q) 对老年小鼠血管内皮衰老和功能的长期影响.
- 阐明D+Q影响内皮细胞,线粒体功能和血管反应的分子机制.
主要方法:
- 长期给予D+Q (5mg/kg+50mg/kg每两周一次,持续8个月) 给老年小鼠.
- 在中腔动脉和人静脉内皮细胞 (HUVECs) 中评估衰老标志物 (p21,SA-β-gal).
- 转录组分析,评估ENOS (内皮氧化合成酶) 合和二元化,线粒体功能 (超结构,质量,ROS产生) 和血管扩张试验.
主要成果:
- 在老化动脉和HUVEC中,D+Q治疗显著降低了内皮衰老标志物.
- 该疗法恢复了内皮完整性,逆转了与年龄相关的eNOS脱,增加了氧化的生物可用性,并改善了线粒体平衡 (减少了ROS,恢复了超结构).
- D+Q增强了内皮依赖的血管扩张和老化中枢动脉的血流.
结论:
- 使用D + Q老化疗法清除老化的内皮细胞有效减轻动脉衰老.
- 治疗效益与恢复线粒体功能和增强eNOS活动有关.
- 老化疗法具有治疗与年龄相关的血管功能障碍的巨大潜力.
相关概念视频
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
01:27Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229